Controversy Over Restasis Patents is Misplaced
CONTROVERSY OVER RESTASIS PATENTS IS MISPLACED (This article first appeared on IPWatchDog) In his 2018 State of the Union speech, President Trump placed reducing the price of prescription drugs at the top of his agenda. How can he do this without harming the profit incentive that drive R&D for innovative treatments and cures? The President